chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pfizer 3/18 and 4/12. Positive on 9/6 admitted 9/6 to current
The heart rate increased  to 135.  We had to go to urgent care and seek treatment.  We later when to our primary physician who confirmed high heart rate and prescribed Metoprolol Tartrate 25 mg.  However I have been taking it since more than 4 weeks now and when I stop taking it the heart rate increases again.  I never had the high heart rate problem ever before.
Hypotonic/Hyporesponsive episode on day of vaccine, followed by irritability. Family (Mom) can provide specifies about vaccine clinic.
Woke up with muscle and joint pains, heart rate in the 100s, fever, and severe headache, with sharp, shooting pain in both sides of the head (occipital, parietal areas).  Managed with tylenol and ibuprofen every 4-6 hours.  Symptoms persisted beyond 24 hrs, fever went up to as high as 102.7F.  Today is day 4 after vaccine administration. I currently have 100.9 temp, heartrate at 104, my normal is between 70-80. fatigue and muscle and joint pains have subsided, but headache/migraine remains, so do the periodic stabbing pain on bilateral areas in my head. Fever subsides with tylenol, but headache is persistent even with ibuprofen.
patient states she had arm pain at the site of injection that worsened throughout the week. went to ED on 11/3/2022 for back pain and bilateral leg weakness and numbness to the point of not being able to walk that started the day before. had associated loss of bladder control. in the ED pt had decreased anal sphincter tone and saddle anesthesia and was admitted to the hospital.
headache, chills, sweats, aches, generally felt horrible - this lasted two days  lingering - swollen and sore gland in armpit
Local reaction at inj. site. 4" in diameter, reddened area. Area firm and warm to touch. Pt's BP 145/82.
Within the first couple of hours after vaccine I had an adverse reaction at the injection site.  The area around the area around the injection site was painful, red, swollen, hard, and warm to the touch.  The area of pain covered approximately a 6 inch circumference around the area and the reddened swollen area covered about a 3 inch circumference area.
This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. No information regarding the patient's pertinent medical history, concomitant medications, drug reactions or allergies was provided. On 12-MAY-2017, the patient was vaccinated with an incorrectly stored dose of GARDASIL 9 injection, lot # M034780 with expiration date 15-APR-2019 (dose, route and site of administration were not reported). GARDASIL 9 was stored in temperature 34 degrees Fahrenheit for 4 hours and 40 minutes. There was previous temperature excursion and the digital data logger was involved in recording the excursion. There was no product quality complaint involved in this case. This is one of several reports received from the same reporter. Additional information has been requested.; Sender's Comments: US-009507513-1705USA015612: US-009507513-1705USA015613: US-009507513-1705USA015614: US-009507513-1705USA015617: US-009507513-1705USA007801:
Pt called on 3/24/03 to state she believes to have acquired arthritis as a result of receiving the flu vaccine.
mini stroke; This is a spontaneous report from a contactable consumer (patient). A 45-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/Lot number was not reported) via an unspecified route of administration, administered in left arm, on 30Mar2021 at 09:00, as a single dose, for COVID -19 immunisation. The patient's medical history included slight issues with cholesterol and pre diabetic, but the patient has been healthy. The patient has no known allergies and other medical histories. Concomitant medication was not reported. On 03Apr2021, 4 days after the patient received the vaccine shot, he was diagnosed with a mini stroke. The patient was shocked as he was too young and have had no medical issues in his entire life, only change was the shot. The patient also experienced numbness in his right arm and hand which subsided but he still has some numbness on the right side of this face. The patient was hospitalized for 1.5 days and treatment included taking low dose aspirin and Lipidore (as reported). The patient had no COVID prior vaccination and no COVID tested post-vaccination, the patient also had no other vaccine in four weeks and other medications in two weeks. Outcome of the event was recovering. Event resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care, hospitalization, and disability or permanent damage.  Information on the Lot/Batch number has been requested.
who stopped getting it years ago when working every time would get sick, started again getting them and same thing happen (reoccurrence); Initial information received on 15-Feb-2022 regarding an unsolicited valid Social Media non-serious case received from a patient.  This case involves a patient of unknown demographics who stopped getting it years ago when working every time would get sick, started again getting them and same thing happen (reoccurrence) with the flu while receiving Influenza Vaccine.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  On an unknown date, patient started taking Influenza Vaccine (dose, form, route, strength, frequency, lot and batch number: unknown) in an unknown administration site for immunization.   On an unknown date 8 years ago, the patient received a  dose of suspect Influenza Vaccine (dose, form, route, strength, frequency, lot and batch number: unknown) in unknown administration site for immunization. Patient took the last dose on an unknown date 4 years ago.  On an unknown date the patient stopped getting it years ago when working every time would get sick, started again getting them and same thing happen (reoccurrence) (illness) (unknown latency) following the administration of Influenza vaccine.  Reportedly, the patient had stopped taking the flu vaccine, was getting it years ago when working every time, would get sick with the flu. Further said that about 8 years ago, patient had started again getting them & same thing happen (reoccurrence) (flu) (onset and latency: unknown). Further said that had stopped again last one was 4 years ago. It was unknown if the patient experienced any additional symptoms/events.  It was not reported if the patient received a corrective treatment for the event illness.   At time of reporting, the outcome was Unknown for the event illness.
On 4-12-08 was seen for urticaria left upper arm.  On 4-10-08 was given VARIVAX and Hep A.
This spontaneous report as received from a nurse refers to an unspecified number of patients of unknown age and gender. On 25-NOV-2014 the patient was vaccinated with an improperly stored VAQTA (lot # J000366, expiry date 22-AUG-2015) (dosing regimen, route and frequency unknown). No concomitant medications were reported. No adverse effect was reported. This is one of the several reports received from the same reporter. Additional information has been requested.
PFIZER-BIONTECH COVID-19 VACCINE EUA.  Administration error:   Individual vaccinated on 4/12/21 with consent form stating had received only 1 dose of Pfizer COVID-19 vaccine on 2/23/21 at another location.  Later, it was discovered that the individual had received both doses of Pfizer COVID-19 vaccine at the pharmacy. Patient received an additional dose but has no adverse reactions reported to date.
PATIENTS MOTHER REQUESTED VACCINATIONS IN THE PHARMACY AFTER COMING FROM THE DOCTORS OFFICE NEEDING TO BE UPDATED ON VACCINATIONS. AFTER CONSULTING SYSTEM, PATIENT WAS GIVEN ADACEL, MENVEO, AND GARDASIL, PATIENT'S MOTHER WAS ASKED IF SHE RECEIVED ANY VACCINATIONS PRIOR TO BEING GIVEN ALL THREE VACCINATION AND PATIENTS MOTHER STATED NO, PATIENT ONLY RECEIVED BLOOD WORK. PATIENT DISPLAYED NO ADVERSE AFFECTS AFTER BEING GIVEN ALL THREE VACCINATIONS. PATIENTS MOTHER WAS CALLED 2 HOURS AFTER THE VACCINATION WAS GIVEN AND THE ERROR WAS DISCOVERED AND TOLD TO MONITOR PATIENT FOR SIGNS OF ABNORMALITIES.
102 deg F temp; shivering; abnormal general body fatigue; Atelectasis; double blood clot in left lung lower left lobe; This is a spontaneous report from a contactable consumer (Patient). A 68-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration, administered in Arm Right on 01Apr2021 17:00 (Batch/Lot number was not reported) at the age of 68-years-old as single dose for covid-19 immunisation. The COVID-19 vaccine was administered at Doctor's office/urgent care. Medical history included Inclusion Body Myositis, Sjogren's syndrome and Known allergies included Penicillin, Lamisil, Sulfa drugs. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient concomitant medication included unspecified other medications in two weeks. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Got up 9:30AM on 14Apr2021. Experienced abnormal general body fatigue. Began shivering at 1:00 PM and went back to bed. 102 degree F temp at 3:00 PM. Called primary care physician, who advised we go to Emergency room (ER). Got into ER about 6:00pm. Covid polymerase chin reaction (PCR) Nasal Swab test negative, full viral panel negative. Chest X-Ray showed some Atelectasis, Computerised tomogram (CAT) scan revealed double blood clot in left lung lower left lobe. Sent to Hospital at about 1:00 AM 15Apr2021. Treatment with 16ml/hr Heparin plus 5mg/day warfarin. Discharged 06:00 PM on16Apr2021. Adverse event resulted in: [Emergency room/department or urgent care, Hospitalization, Life threatening illness (immediate risk of death from the event)]. The outcome of the events was recovering. Information on the lot/batch number has been requested.
sore arm; Chills; Fever; This spontaneous case was reported by a patient and describes the occurrence of PAIN IN EXTREMITY (sore arm), CHILLS (Chills) and PYREXIA (Fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm), CHILLS (Chills) and PYREXIA (Fever). At the time of the report, PAIN IN EXTREMITY (sore arm), CHILLS (Chills) and PYREXIA (Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.  The patient was concerned about multisystem Inflammatory Syndrome (MIS) inflammatory death since she had Covid prior to the first vaccine.    This case was linked to MOD-2021-168297 (Patient Link).
This spontaneous report as received from a licensed practical nurse refers to a patient of unknown age and unknown gender. The patient pertinent medical history was not reported. On 08-APR-2014, the patient was vaccinated with ZOSTAVAX (dose strength and route was not reported) (lot # J011828 and expiry date: 26-DEC-2014, reported as 16-DEC-2014) which was improperly stored. Primary reporter was reporting excursion of 6 F since 01-JUN-2013 (confirmed date) affecting ZOSTAVAX, nurse also reported that products were not stored in an overall average support range of -58 degree F and 5 degree F. No adverse effects reported. No product quality complaint (PQC) was reported for ZOSTAVAX. This is one of the several reports from the same reporter. Additional information has been requested.
This spontaneous report as received from a health professional refers to an unspecified number of patient of unknown demographics. The concomitant medications, medical history and concomitant medications were unknown. On an unknown date in 2016 (reported as on or after 24-MAR-2016) the patients were vaccinated with unspecified number of improperly stored doses of RECOMBIVAX HB. The vaccine was stored at 47 F for 72. hours. There were no previous excursions. No adverse effects were reported. This is one of the several reports received from the same reporter. Additional information has been requested.
patient is 2 weeks over COVID symptons; This case was reported by a pharmacist and described the occurrence of covid-19 in a 81-year-old female patient who received Herpes zoster (Shingrix) (batch number 7323T, expiry date 6th May 2022) for prophylaxis.   On 7th October 2020, the patient received Shingrix. On an unknown date, less than 2 months after receiving Shingrix, the patient experienced covid-19. On an unknown date, the outcome of the covid-19 was unknown.   It was unknown if the reporter considered the covid-19 to be related to Shingrix.  Additional details were provided as follows: The pharmacist stated the patient was 2 weeks over COVID symptoms and they would like the time frame for the second dose of Shingrix.  The reporter did not consent to follow up.
Maculopapular rash to chest area was given benadryl by parent 30 min before receiving vaccine.
pt recvd vax 20OCT94 & 26OCT94 exp red welts on inner arm, back, chest which itched;30OCT94 devel swelling of both feet & the 3 middle fingers of both hands;
Felt dizzy bending over; Lack of appetite.; Fell; Acting draggy; Fever 101 F; Difficulty urinating.; A spontaneous report was received from a consumer, concerning a 68-years-old male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events difficulty in urinating/dysuria, fever, felt dizzy bending over/dizziness postural, fall, acting draggy/lethargy and lack of appetite.  The patient's medical history included polycythemia and hypertension. On an unspecified date in Oct 2020, the patient experienced COVID. No relevant concomitant medications were reported.  On 05 Feb 2021, at 12:00 pm, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (batch number: 011M20A) on left arm for prophylaxis of COVID-19 infection.  On 05 Feb 2021, the night of vaccination, the patient experienced the event difficulty in urinating (dysuria). On 06 Feb 2021 (early morning), the patient developed the events fever with a body temperature of 101 F, felt dizzy upon bending over and fell. The patient was acting draggy and had lack of appetite.  Treatment details included Tylenol for fever.  Action taken with mRNA-1273 in response to the events was unknown.   The outcome of events, difficulty urinating, fever 101 F, felt dizzy bending over and fell was considered as resolved on 6 Feb 2021. On 07 Feb 2021 the outcome of events, acting draggy, lack of appetite was resolved.; Sender's Comments:  MOD21-022987:
Information has been received from a licensed practical nurse concerning a 15 month old female who on 19-JUN-2007 was vaccinated with varicella virus vaccine live (Oka/Merck) (Lot # 657404/0592U). The patient developed an immediate injection site rash (left arm). The patient was treated with Benadryl and ice. Subsequently, the patient recovered. Unspecified medical attention was sought. No product quality complaint was involved. Additional information has been requested.
pt said when she got the covid vax while walking away she had tingling in her right foot.  It eventually moved to both feet, both arms and hands.  Sometimes the tingling is in the face.  This symptom has not gone away since taking the injection.  The tingling sensation was getting worse so she went to her doctors office On 5/10/2021 where she saw a resident doctor.  He did a stroke test that was ruled out.  She had blood test with normal results. Since the symptoms were not going away she went to a Neurologist.  He did a nerve damage test with normal results.  They could provide a DX since they cannot determine any reason for her symptoms other than it happened as soon as she had the injection.  As of today 5/27/21 she still has the tingling and it gets worse with walking or activity.  She is scheduled to get her 2nd dose today but has decided not take it.
Vaccine dates: 3/11/21, 4/1/21, 8/26/21  a 36 y.o. male admitted for postoperative Complication(s): including  postoperative complication(s) Ileus versus bowel obstruction and three small openings in midline wound.     History of Present Illness a 36 y/o male who is status post exp lap, LOA, and small bowel resection for complicated Crohn's Disease on 10/1/21. He had a prolonged hospital stay due to an ileus, an abscess with drain placement and removal, and a surgical site infection. He was released on 10/13/21. Since that time, his recovery has been up and down. He will feel good a few days and then have one bad day where he feels bloated and has less stool output. He used tylenol and ibuprofen to control his pain. Overall was slowly improving from an extensive surgical procedure.    On Sunday, he started to experience a new pain on the right side of his incision. It was burning pain without relief from medications. He ate scrambled eggs yesterday (his last meal) and vomited. When he vomited he felt his incision open up a bit and yellowish drainage poured out. There is a small opening on the superior aspect of his healing incision, < 1 cm, which is open. There is a dry gauze pad to catch any fluid. Last evening the pain got worse and he presented to his local emergency room.    On arrival, he appears comfortable. Pain well controlled. Denies nausea and vomiting. Concerned about his incisional openings and the absence of his Crohn's medications over the past few weeks. He has been receiving IV fluids over the past few weeks for dehydration.
arm sort of itching; arm kind of red; arm a little swollen; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PRURITUS (arm sort of itching), INJECTION SITE ERYTHEMA (arm kind of red) and PERIPHERAL SWELLING (arm a little swollen) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no medical history provided).    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Jan-2021, the patient experienced INJECTION SITE PRURITUS (arm sort of itching), INJECTION SITE ERYTHEMA (arm kind of red) and PERIPHERAL SWELLING (arm a little swollen). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, INJECTION SITE PRURITUS (arm sort of itching), INJECTION SITE ERYTHEMA (arm kind of red) and PERIPHERAL SWELLING (arm a little swollen) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   no concomitant medication provided
ADVERSE REACTION TODAY: hot, itchy rash on forearms made up of tiny blisters -- > no tx thus far -- >  OTHER SIDE EFFECTS: Immediate onset: muscle pain at site of injection Onset about 11 hours post-vaccination: fever, chills, muscle aches, site of injection red and in worse pain, headache Onset about 24 hours post-vaccination: earache off and on Onset about 48 hours post-vaccination: fever spiked at 101.8 Onset about 96 hours post-vaccination: lethargic, headache
Sore arm, then soreness went to both arms(shot #1 in other arm), also pain in hips, then knee.  Urinary burn and slow stream and many urges.  Worsen in last week approx 4-09-2021.
This case was reported by a healthcare professional and described the occurrence of antigenemia in a 18-year-old female subject who was vaccinated with ENGERIX B (Glaxosmithkline). On 10 April 2009 the subject received 2nd dose and ENGERIX B (20 mcg, unknown). On 13 April 2009, 3 days after vaccination with ENGERIX B, the subject experienced antigenemia. On 13 April 2009, her blood tested positive for hepatitis B surface antigen. Her blood had not been redrawn at the time of reporting, so it was unknown if it has resolved. The nurse believed that that subject received the 20 mcg dose. At the time of reporting the outcome of the event was unspecified. The healthcare professional considered the event was probably related to vaccination with ENGERIX B.
Fatigue; mouth so dry; This is a spontaneous report from a contactable consumer. An 85-year-old female patient (mother) received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number: EL8982; Expiration Date: 31May2021), dose 1 via an unspecified route of administration, administered in Arm Right (once to upper right arm) on 07Feb2021 08:57 (at the age of 85-year-old) as dose 1, single for COVID-19 immunization. Medical history included has allergies, cannot hear very well from an unknown date and unknown if ongoing. There were no concomitant medications. Patient did not have any history of all previous immunization with the Pfizer vaccine and not received any additional vaccines administered on same date of the Pfizer suspect. Patient prior vaccinations (within 4 weeks) were none reported. Patient family medical history relevant to adverse events were none reported. On 07Feb2021, patient experienced mouth so dry, fatigue on 07Feb2021 12:00. Reporter that it showed the fatigue was listed, but the dry mouth was most concerning. The dry mouth started day one, and her mother was still had it. Fatigue started the afternoon, about 12PM. Stated that her mother cannot hear very well either and no further details provided. Reporter wanted to know that her mother should just keep hydrated. Patient did not visit emergency room and physician office for adverse events. There was no investigation assessment and no relevant tests. The clinical outcome of events was not recovered.  Follow-up attempts completed. No further information expected.
Blurred vision began one week after vaccination. Pt reports it has gotten better, but is still intermittent. Pt reported having had cataract surgery the previous year (March 2020) so recommended to discuss with opthamologist
Severe swelling, itching and redness at the injection site.  So far swelling has lasted 3 days, has not yet gone down. Currently taking antihistamines to treat the itching.
Myalgia, Arthralgia, 'lower neck stiffness and pain' post vaccination  Narrative: employee endorses being seen by her PCP who reported the symptoms probably weren't related to receiving the vaccine
Patients first dose of Covid vaccine was Pfizer. This nurse mistakenly gave a Moderna vaccine. Patient monitored for required amount of time, no adverse effects noted. MD aware of event as well as supervisor.
pt got vaccine 4/7..  on 4/8 he said his whole body broke out in a rash. he said he has trouble breathing often and has asthma and "wasn't sure if his breathing was worse with the vaccine or not, since he has that trouble often". he reported this adverse rxn on 4/28 when he came for his 2nd dose. we told him we cannot do the vaccine today, he needs to go to the hospital for another dose if they will administer it, he needs to call
About 6 days I developed a rash by injection site that was itchy, red and little swollen and felt warmer to the touch. It is about 3 inches long by 2 inches wide. Currently only affecting the injection site area. On day 2 of reaction, symptoms are improving: mild itching and redness. Less swelling
right breast implant contracture 3 months after second covid 19 vaccine. no prior symptoms since initial implantation 30 years ago.
This spontaneous report as received from a nurse refers to an unspecified number of patients of unknown age and gender. The nurse reported that on an unknown dates an unspecified number of patients received doses of VAQTA (route, dose, frequency and lot # not reported) that were improperly stored. No adverse experiences reported. No further information provided. This is one of several reports from the same source. Additional information has been requested.